基本信息
views: 202
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Tamminga holds the Lou and Ellen McGinley Distinguished Chair and the McKenzie Chair in Psychiatry at the University of Texas Southwestern Medical School and is the Chairman of the Department of Psychiatry and the Chief of the Translational Neuroscience Division in Schizophrenia at UTSW. She received her M.D. degree from Vanderbilt University and completed residency training in psychiatry at the University of Chicago. She served on the University of Chicago faculty from 1975 to 1979 and moved to the NINDS for training in Neurology in 1978. After joining the faculty at the University of Maryland Medical School in 1979, she practiced research, clinical care and teaching there until joining the faculty at UT Southwestern Medical School in 2003.
Dr. Tamminga is currently a member of NIMH’s National Advisory Board and has served on the Board of Scientific Counselors of the National Institute of Mental Health and the National Institute of Drug Abuse, as Council member and President of the American College of Neuropsychopharmacology, as a Member and Chair of the Psychopharmacological Drugs Advisory Committee of the FDA, as well as consultant for the Orphan Products Development Review Group, FDA. She is a member of the Advisory Board of the Brain and Behavioral Research Foundation (NARSAD). She is currently the Deputy Editor of the American Journal of Psychiatry and on the editorial board of several other journals in the field. Dr. Tamminga was elected to the Institute of Medicine of the National Academies of Sciences in 1998 and has served on several IOM committees in that capacity.
The goal of Dr. Tamminga’s research is to examine and understand the mechanisms underlying schizophrenia, especially its most prominent symptoms, psychosis and memory dysfunction, in order to build rational treatments for the illness. She evaluates the function of the living human brain in individuals with and without schizophrenia, using brain imaging techniques. Then, building on this knowledge, she uses human postmortem brain tissue to translate the functional alterations from the living human patient into molecular observations of the illness. Her ultimate goal is to base novel pharmacologies for psychosis and memory dysfunction on these observations and to use the altered in vivo imaging and postmortem molecular changes as biomarkers and targets for identifying animal models of disease and novel active pharmaceuticals.
Research Interests
Papers共 418 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Personalized Medicine in Psychiatry (2024): 100124
NATURE NEUROSCIENCE (2023)
Cited0Views0Bibtex
0
0
Audrey Berardi, Jennifer A. Brown,Brooke S. Jackson,Ling-Yu (Beryl) Huang,David A. Parker,Courtney R. Burton,Scot K. Hill,Elliot S. Gershon,Godfrey D. Pearlson,Carol K. Tamminga,Sarah K. Keedy,Matcheri S. Keshavan,
Biological Psychiatryno. 9 (2023): S268-S268
Chelsea Kiely,Mite Mijalkov,Shashwath Meda, Jolie Hoang,Joana Pereira,Elena I. Ivleva,Giovanni Volpe,Yanxun Xu,Adam Lee,Brett A. Clementz,Carol Tamminga,Godfrey Pearlson,
Biological Psychiatryno. 9 (2023): S173-S173
bioRxiv : the preprint server for biology (2023)
Biological Psychiatryno. 9 (2023): S159-S159
Innovations in clinical neuroscienceno. 1-3 (2022): 26-32
Cited3Views0WOSBibtex
3
0
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn